What: Exclusive media briefing by medical experts on HPV-related head and neck cancer, including a patient perspective, from the Multidisciplinary Head and Neck Cancer Symposium. Much of the discussion about HPV has been about its impact on gynecologic cancers. However, new research has shown HPV to be a significant contributor to many oral and head and neck cancers, too.
(Audio recordings and slides available after the media briefing on ASTRO’s Web site (www.astro.org/pressroom/presskit).
When: Friday, February 26, at 12:45 p.m. – 1:30 p.m. Mountain time (2:45 p.m. – 3:30 p.m. Eastern time) Who: Paul Harari, M.D., University of Wisconsin, Madison, Wis., Moderator Maura L. Gillison, M.D., Ph.D., The Ohio State University, Columbus, Ohio Andy Trotti, M.D., H. Lee Moffit Cancer Center, Tampa, Fla. Stephen Reynolds, Survivor Topics discussed will be:• What is the HPV virus? What are the modes of transmission; infection prevalence rates in the U.S. for males and females; time delay between infection and cancer? HPV is a newly recognized factor. What are the rising rates of HPV; prognostic value of HPV testing. Should all oral head and neck cancers be tested? Does smoking history modify an otherwise good prognosis?• Favorable prognosis begs the question: Can we reduce treatment intensity and maintain high cures? What are some of the potential reduction approaches; Current Clinical Trials evaluating HPV; Funding gap for HPV clinical trials.• A patient’s perspective.
How: Register for the webcast at https://astro.webex.com/astro/j.php?ED=119069312&RG=1&UID=0&RT=MiMxMQ%3D%3D. You will receive a confirmation e-mail with instructions for joining the meeting.
You may have the webcast call you directly or you may dial in to one of the numbers below.* Call-in toll-free number (U.S./Canada): 1-866-699-3239* Call-in toll number (U.S./Canada): 408-792-6300* Access code: 680 868 616
RSS